Plus Therapeutics inventory sees decreased goal after softer-than-expected Q2 outcomes By Investing.com
On Tuesday, Ascendiant Capital revised its value goal for NASDAQ:PSTV, Plus Therapeutics…
Search
Have an existing account?
Sign In
